Miwa Matsumoto

Statistics

Publications

Citations

228

H-Index

Active since

2002

Affiliations

Mochida Pharmaceutical (Japan)(Current)

Miwa Matsumoto is an author at Mochida Pharmaceutical (Japan) specializing in pharmacology, drug discovery, and structure-activity relationship analysis.

Publications per year

2002–2010

Publications

Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice

Miwa Matsumoto, Masataka Sata, Daiju Fukuda et al. · Atherosclerosis · 2007 · 145 citations

Life Sciences, Biochemistry, Pharmacology +16

Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as a Factor Xa Inhibitor. II. Substituent Effect on Biological Activities.

Hidemitsu Nishida, Yutaka Miyazaki, Takafumi Mukaihira et al. · Chemical and Pharmaceutical Bulletin · 2002 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Effect of Heel Lifts on Plantarflexor and Dorsiflexor Activity During Gait

Marie A. Johanson, Jasmine Allen, Miwa Matsumoto et al. · Foot & Ankle International · 2010 · 23 citations

Education, Kinesiology, Sports Medicine +14

Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors IV. A Series of New Derivatives Containing a Spiro[5H-oxazolo[3,2-a]pyrazine-2(3H),4'-piperidin]-5-one Skeleton

Hidemitsu Nishida, Takafumi Mukaihira, Fumihiko Saitoh et al. · Chemical and Pharmaceutical Bulletin · 2004 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors VI. A Series of New Derivatives Containing N,S- and N,SO2-Spiro Acetal Scaffolds

Fumihiko Saitoh, Hidemitsu Nishida, Takafumi Mukaihira et al. · Chemical and Pharmaceutical Bulletin · 2007 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

1–5 of 6